Zhejiang Shengda Pharm (603079) — Cash Flow-to-Debt Ratio
Zhejiang Shengda Pharm (603079) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥45.27 Million could theoretically repay 0% of its total liabilities (CN¥542.15 Million) in one year. See Zhejiang Shengda Pharm leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shengda Pharm Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Zhejiang Shengda Pharm across 14 annual periods. For the full cash flow conversion analysis, see Zhejiang Shengda Pharm (603079) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shengda Pharm (2012–2025)
Year-by-year debt coverage analysis for Zhejiang Shengda Pharm. Check 603079 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | CN¥138.88 Million | CN¥583.75 Million | ▼ -19.3% |
| 2024 | 0.29x | CN¥147.88 Million | CN¥501.34 Million | ▲ +105.7% |
| 2023 | 0.14x | CN¥64.42 Million | CN¥449.20 Million | ▲ +9.8% |
| 2022 | 0.13x | CN¥40.72 Million | CN¥311.76 Million | ▼ -25.0% |
| 2021 | 0.17x | CN¥74.46 Million | CN¥427.84 Million | ▼ -80.4% |
| 2020 | 0.89x | CN¥333.20 Million | CN¥375.80 Million | ▲ +840.2% |
| 2019 | 0.09x | CN¥58.55 Million | CN¥620.88 Million | ▼ -54.9% |
| 2018 | 0.21x | CN¥88.69 Million | CN¥424.29 Million | ▼ -52.4% |
| 2017 | 0.44x | CN¥95.33 Million | CN¥217.27 Million | ▲ +81.1% |
| 2016 | 0.24x | CN¥73.00 Million | CN¥301.35 Million | ▼ -69.7% |
| 2015 | 0.80x | CN¥148.07 Million | CN¥185.05 Million | ▲ +419.6% |
| 2014 | 0.15x | CN¥34.40 Million | CN¥223.40 Million | ▼ -67.2% |
| 2013 | 0.47x | CN¥105.28 Million | CN¥224.00 Million | ▲ +37.2% |
| 2012 | 0.34x | CN¥110.08 Million | CN¥321.43 Million | — |